Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PDAC - Pancreatic Ductal Adenocarcinoma”

677 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 677 results

Not applicableStudy completedNCT06980792
What this trial is testing

Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases

Who this might be right for
Pancreas NeoplasmsLiver MetastasisPancreas Ductal Adenocarcinoma+3 more
Azienda Ospedaliero-Universitaria di Modena 90
Not applicableUnknownNCT06155136
What this trial is testing

RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan

Who this might be right for
Pancreatic Cancer Metastatic
Servier Affaires Médicales 163
Early research (Phase 1)Looking for participantsNCT06673017
What this trial is testing

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Adenocarcinoma+1 more
PanTher Therapeutics 26
Not applicableLooking for participantsNCT07224750
What this trial is testing

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)CholangiocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)+3 more
City of Hope Medical Center 1,000
Testing effectiveness (Phase 2)Study completedNCT02810418
What this trial is testing

Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors

Who this might be right for
NeoplasmsPancreatic Neoplasms
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02498613
What this trial is testing

Cediranib in Combination With Olaparib in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+23 more
National Cancer Institute (NCI) 122
Early research (Phase 1)UnknownNCT04258072
What this trial is testing

Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma.

Who this might be right for
Pancreas Cancer
Samsung Medical Center 24
Early research (Phase 1)Study completedNCT04106856
What this trial is testing

Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma+4 more
University of Utah 22
Not applicableUnknownNCT04189393
What this trial is testing

Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery

Who this might be right for
Gastrointestinal CancerColorectal CancerPancreatic Cancer+8 more
Radboud University Medical Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT06825546
What this trial is testing

Icaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Advanced Pancreatic Ductal Adenocarcinoma
Sir Run Run Shaw Hospital 70
Testing effectiveness (Phase 2)Study completedNCT04896073
What this trial is testing

Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)

Who this might be right for
Adenosquamous Carcinoma of the Pancreas
National Cancer Institute (NCI) 16
Not applicableNot Yet RecruitingNCT06655142
What this trial is testing

OSCAR II STUDY - The ONCObind CTC Removal Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Metastatic Colorectal Carcinoma (mCRC)
ExThera Medical Corporation 120
Testing effectiveness (Phase 2)Study completedNCT05052567
What this trial is testing

CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Qilu Pharmaceutical Co., Ltd. 50
Not applicableUnknownNCT05201729
What this trial is testing

Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma, PDAC
Ruijin Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04913337
What this trial is testing

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
MesotheliomaGlioblastomaRenal Cell Carcinoma+12 more
NGM Biopharmaceuticals, Inc 179
Early research (Phase 1)Looking for participantsNCT07106827
What this trial is testing

GV20-0251 in Advanced or Refractory Solid Tumors

Who this might be right for
HCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more
West China Hospital 10
Not applicableLooking for participantsNCT05475366
What this trial is testing

Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures

Who this might be right for
Carcinoma, Pancreatic DuctalPrognosis
Institut Curie 85
Early research (Phase 1)Study completedNCT02259114
What this trial is testing

A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)

Who this might be right for
NUT Midline CarcinomaTriple Negative Breast CancerNon-small Cell Lung Cancer With Rearranged ALK Gene/Fusion Protein or KRAS Mutation+3 more
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 47
Large-scale testing (Phase 3)Not Yet RecruitingNCT07445295
What this trial is testing

Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Chipscreen Biosciences, Ltd. 558
Testing effectiveness (Phase 2)Study completedNCT02583477
What this trial is testing

Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
AstraZeneca 23
Next Page